Items where Salford Author is "Krstic- Demonacos, M"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 19.

Article

Garva, R, Thepmalee, CT, Yasamut, U, Sudsaward, S, Guazzelli, A, Rajendran, R, Tongmuang, N, Khunchai, S, Meysami, P, Limjindaporn, T, Yenchitsomanus, P, Mutti, L, Krstic- Demonacos, M and Demonacos, C 2019, 'Sirtuin family members selectively regulate autophagy in osteosarcoma and mesothelioma cells in response to cellular stress' , Frontiers in Oncology .
[img]
Preview
[img]

Guazzelli, A, Meysami, P, Bakker, E, Bonanni, E, Demonacos, C, Krstic- Demonacos, M and Mutti, L 2019, 'What can independent research for Mesothelioma achieve to treat this orphan disease?' , Expert Opinion on Investigational Drugs, 28 (8) , pp. 719-732.
[img]

Guazzelli, A, Meysami, P, Bakker, E, Demonacos, C, Giordano, A, Krstic- Demonacos, M and Mutti, L 2019, 'BAP1 status determines the sensitivity of malignant mesothelioma cells to gemcitabine treatment' , International Journal of Molecular Sciences, 20 (2) , p. 429.
[img]
Preview
[img]

Tian, K, Bakker, EY, Hussain, M, Guazzelli, A, Alhebshi, H, Meysami, P, Demonacos, C, Schwartz, J-M, Mutti, L and Krstic-Demonacos, M 2018, 'p53 modeling as a route to mesothelioma patients' stratification and novel therapeutic identification' , Journal of Translational Medicine, 16 (282) .
[img]
Preview
[img]

Bakker, EY, Tian, K, Mutti, L, Demonacos, C, Schwartz, J-M and Krstic-Demonacos, M 2017, 'Insight into glucocorticoid receptor signalling through interactome model analysis' , PLOS Computational Biology, 13 (11) .
[img]
Preview
[img]
Preview

Bakker, EY, Guazzelli, A, Ashtiani, F, Demonacos, C, Krstic-Demonacos, M and Mutti, L 2017, 'Immunotherapy advances for mesothelioma treatment' , Expert Review of Anticancer Therapy, 17 (9) , pp. 799-814.
[img]
Preview
[img]

Guazzelli, A, Bakker, EY, Tian, K, Demonacos, C, Krstic- Demonacos, M and Mutti, L 2017, 'Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma' , Expert Opinion on Investigational Drugs, 26 (8) , pp. 933-944.
[img]
Preview

Qattan, MY, Bakker, EY, Rajendran, R, Wei-Chen Chen, D, Saha, V, Liu, J, Schwartz, J, Mutti, L, Demonacos, C and Krstic- Demonacos, M 2017, 'Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia' , PLoS ONE, 12 (6) , e0178606.
[img]
Preview
[img]

Bakker, EY, Guazzelli, A, Krstic-Demonacos, M, Lisanti, MP, Sotgia, F and Mutti, L 2017, 'Current and prospective pharmacotherapies for the treatment of pleural mesothelioma' , Expert Opinion on Orphan Drugs, 5 (6) , pp. 455-465.
[img]
Preview
[img]

Guazzelli, A, Bakker, EY, Krstic-Demonacos, M, Lisanti, MP, Sotgia, F and Mutti, L 2017, 'Anti-CTLA-4 therapy for malignant mesothelioma' , Immunotherapy, 9 (3) , pp. 273-280.
[img]
Preview

Kuroda, k, Fukuda, T, Krstic-Demonacos, M, Demonacos, C, Okumura, K, Isogai, H, Hayashi, M, Saito, K and Isogai, E 2017, 'miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway' , BMC Cancer, 17 , pp. 33-43.
[img]
Preview

Singh, S, Rajendran, R, Kuroda, K, Isogai, E, Krstic-Demonacos, M and Demonacos, C 2016, 'Oxidative stress and breast cancer biomarkers : the case of the cytochrome P450 2E1' , Journal of Cancer Metastasis and Treatment, 2 , pp. 268-276.
[img]
Preview

Fiorillo, M, Lamb, R, Tanowitz, H, Mutti, L, Krstic- Demonacos, M, Cappello, A, Martinez-Outschoorn, U, Sotgia, Federica and Lisanti, MP 2016, 'Repurposing atovaquone : targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells' , Oncotarget, 7 (23) , pp. 34084-34099.
[img]
Preview

Guazzelli, A, Hussain, M, Krstic- Demonacos, M and Mutti, L 2015, 'Tremelimumab for the treatment of malignant mesothelioma' , Expert opinion on biological therapy, 15 (12) , pp. 1819-1829.
[img]

Hussain, M, Tian, K, Mutti, L, Krstic-Demonacos, M and Schwartz, JM 2015, 'The expanded p53 interactome as a predictive model for cancer therapy' , Genomics and Computational Biology, 1 (1) , e20.
[img]
Preview

Bakker, EY, Qattan, M, Mutti, L, Demonacos, C and Krstic- Demonacos, M 2015, 'The role of microenvironment and immunity in drug response in leukemia' , Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863 (3) , pp. 414-426.
[img] [img]
Preview

Kuroda, K, Fukuda, T, Isogai, H, Okumura K, K, Krstic-Demonacos, M and Isogai, E 2015, 'Antimicrobial peptide FF/CAP18 induces apoptotic cell death in HCT116 colon cancer cells via changes in the metabolic profile' , International Journal of Oncology, 46 (4) , pp. 1516-1526.
[img]
Preview

Conference or Workshop Item

Al-Sudani, B, Krstic- Demonacos, M and Ragazzon, PA 2015, Novel therapies for cancer treatment : designing high affinity and selectivity ligands against SIRT1 , in: EuroMedLab Paris 2015, 21-25 June 2015, Paris, France. Item not available from this repository.

Hussain, M, Stutchbury, B, Tian, K, Atalay, R, Schwartz, JM and Krstic-Demonacos, M 2014, Applications of p53 interactome analysis to personalised drug discovery , in: Conference: International Work-Conference on Bioinformatics and Biomedical Engineering (IWBBIO 2014), 7-9 April, 2014, Universidad de Granada, Granada, Spain. Item not available from this repository.

This list was generated on Wed Jan 29 01:03:22 2020 UTC.